Helomics

Helomics develops and maintains the D-Chip database, which contains de-identified data extracted from clinical trials on tumor responses to drugs. It leverages AI-driven bioinformatics to derive insights from this data, enriching disease databases to enhance the effectiveness of cancer treatments. In addition to providing proprietary precision diagnostics in oncology, Helomics also offers boutique CRO services. Utilizing patient-derived tumor models, combined with extensive multi-omics analyses (genomics, proteomics, and biochemistry), as well as its proprietary bioinformatics platform (D-CHIP), Helomics delivers tailored solutions to meet specific client needs.